Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

JBA (Japanese Bioindustry Association) survey shows growing bioindustry:

This article was originally published in Clinica

Executive Summary

A survey conducted recently by the Japanese Bioindustry Association (JBA) showed that 30 bioventures were established in Japan in 2002, bringing the total number in existence there to 333. Having tracked the trend, the authorities established the Biotechnology Strategy Council, but also see the need to improve the infrastructure to develop the bioindustry sector fully. Part of their efforts will be seen later this year, with the launch of Focus 21, a programme that will help to commercialise R&D achievements. One spin-off will be the development of a ¥00bn ($2.5bn) market for health management, equipment and services.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT061900

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel